肺炎球菌検査市場：方法、技術、製品タイプ、エンドユーザー別-世界予測2025-2030年

肺炎球菌検査市場は、2023年に16億6,000万米ドルと評価され、2024年には18億米ドルに達すると予測され、CAGR 8.99％で成長し、2030年には30億3,000万米ドルに達すると予測されています。

肺炎球菌検査には、肺炎球菌による感染症の検出を目的としたさまざまな診断法が含まれています。肺炎球菌は、特に幼児や高齢者の間で、世界的に重大な罹患率と死亡率の原因となっている細菌です。肺炎球菌検査の必要性は、適切な治療決定を助けるタイムリーで正確な検出の必要性からきており、それによって合併症を減らし、公衆衛生の結果を改善します。肺炎球菌検査の治療は、主に臨床現場、病院、診断研究所で行われ、迅速な診断により、治療の迅速化、ワクチン戦略への情報提供、抗生物質耐性株の蔓延の監視に役立っています。主なエンドユーザーには、ヘルスケアプロバイダー、政府機関、研究機関が含まれます。市場の洞察によると、肺炎と敗血症の発生率の上昇、診断技術の技術的進歩、ヘルスケアインフラに対する世界の認識と投資の増加によって、大きな成長がもたらされています。ポイントオブケア検査とリアルタイムPCRの出現は、高い精度と迅速な結果を提供することで市場拡大を促進しています。疾病の有病率は高いもの、診断サービスが行き届いていない新興市場にはビジネスチャンスがあふれています。費用対効果が高く使いやすい検査ソリューションでこれらの市場に参入すれば、市場シェアを大幅に拡大できます。しかし、高度な診断技術の高コスト、規制上の課題、未発達地域における認識不足など、市場成長には限界があります。また、技術的な障壁や熟練した人材の必要性も課題となっています。革新的な分野は、費用対効果が高く、迅速で多重化された診断検査の開発や、感染予防のためのワクチン血清型カバー率の向上にあります。バイオテクノロジー企業と政府の保健機関との研究資金提供や政策立案における協力関係は、市場拡大にとって有望です。市場の競争は激しく、各社が製品の差別化を図り、進化するヘルスケア需要に効果的に対応するための継続的な研究と技術革新が求められています。

市場力学：急速に進化する肺炎球菌検査市場の主要市場インサイトを公開

肺炎球菌検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 早期診断と早期治療の改善に伴う肺炎球菌検査の採用増加
  • 肺炎球菌性疾患の有病率の急増
  • ワクチンおよび薬剤分子開発のための進行中の臨床試験
• 市場抑制要因
  • 肺炎球菌検査法の開発に伴う高コスト
• 市場機会
  • POC検査の人気の高まり
  • 体外診断（IVD）検査技術への研究開発投資と進歩の増加
• 市場の課題
  • 専門家の不足

ポーターの5つの力：肺炎球菌検査市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：肺炎球菌検査市場における外部からの影響の把握

外部マクロ環境要因は、肺炎球菌検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析肺炎球菌検査市場における競合情勢の把握

肺炎球菌検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス肺炎球菌検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、肺炎球菌検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨肺炎球菌検査市場における成功への道筋を描く

肺炎球菌検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 早期診断と治療の改善による肺炎球菌検査の採用増加
    • 肺炎球菌感染症の罹患数の急増
    • ワクチンと薬物分子の開発のための臨床試験が進行中
  • 抑制要因
    • 肺炎球菌検査メソッドの開発に伴う高コスト
  • 機会
    • POCテストの人気の高まり
    • 体外診断（IVD）の検査技術に対する研究開発投資の増加と進歩
  • 課題
    • 専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 肺炎球菌検査市場：方法別

• 免疫診断
• 分子診断
• ポイントオブケア検査

第7章 肺炎球菌検査市場：技術別

• 酵素免疫測定法
• 免疫蛍光法
• 免疫組織化学
• 核酸配列に基づく増幅
• ポリメラーゼ連鎖反応
• ウエスタンブロットテスト

第8章 肺炎球菌検査市場：製品タイプ別

• アナライザー
• 消耗品

第9章 肺炎球菌検査市場：エンドユーザー別

• 外来手術センター
• 病院・クリニック

第10章 南北アメリカの肺炎球菌検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の肺炎球菌検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの肺炎球菌検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acon Labs Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux S.A.
• Cepheid Inc.
• F-Hoffmann la Roche Ltd.
• Hologic, Inc.
• Meridian Bioscience, Inc. by SD Biosensor
• Novartis AG
• Pfizer Inc.
• Qiagen N.V.
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC

LIST OF FIGURES

• FIGURE 1. PNEUMOCOCCAL TESTING MARKET RESEARCH PROCESS
• FIGURE 2. PNEUMOCOCCAL TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PNEUMOCOCCAL TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PNEUMOCOCCAL TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY WESTERN BLOT TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Pneumococcal Testing Market was valued at USD 1.66 billion in 2023, expected to reach USD 1.80 billion in 2024, and is projected to grow at a CAGR of 8.99%, to USD 3.03 billion by 2030.

Pneumococcal testing encompasses a range of diagnostic methods aimed at detecting infections caused by Streptococcus pneumoniae, a bacterium responsible for significant morbidity and mortality worldwide, particularly among young children and the elderly. The necessity of pneumococcal testing stems from the need for timely and accurate detection that aids in appropriate treatment decisions, thereby reducing complications and improving public health outcomes. Applications of pneumococcal testing are predominantly seen in clinical settings, hospitals, and diagnostic laboratories where rapid diagnosis can expedite treatment, inform vaccination strategies, and help monitor the spread of antibiotic-resistant strains. Key end-users include healthcare providers, government entities, and research institutions. Market insights reveal significant growth influenced by rising incidences of pneumonia and sepsis, technological advancements in diagnostic techniques, and increased awareness and investment in healthcare infrastructure globally. The advent of point-of-care testing and real-time PCR is driving market expansion by offering high accuracy and swift results. Opportunities abound in emerging markets where the prevalence of disease is high but diagnostic services are underserved. Penetrating these markets with cost-effective and easy-to-use testing solutions can markedly expand market share. However, market growth faces limitations such as the high cost of advanced diagnostic technologies, regulatory challenges, and a lack of awareness in underdeveloped regions. Technological barriers and the need for skilled personnel further pose challenges. Areas of innovation lie in the development of cost-effective, rapid, and multiplexed diagnostic tests, as well as enhanced vaccine serotype coverage to preempt infection. Collaboration between biotech companies and governmental health bodies for research funding and policy making is promising for market expansion. The nature of the market is highly competitive, encouraging continuous research and innovation for companies to differentiate their products and meet evolving healthcare demands effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pneumococcal Testing Market

The Pneumococcal Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing adoption of pneumococcal testing with improvement in early diagnosis and treatment
  • Upsurge in the number of prevalence of pneumococcal disease
  • Ongoing clinical trials for development of vaccines and drug molecules
• Market Restraints
  • High cost associated with the development of pneumococcal testing methods
• Market Opportunities
  • Rising popularity for POC tests
  • Increasing R&D investments and advancements in testing technologies for in-vitro diagnostic (IVD)
• Market Challenges
  • Dearth of professionals

Porter's Five Forces: A Strategic Tool for Navigating the Pneumococcal Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pneumococcal Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pneumococcal Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pneumococcal Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pneumococcal Testing Market

A detailed market share analysis in the Pneumococcal Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pneumococcal Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pneumococcal Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pneumococcal Testing Market

A strategic analysis of the Pneumococcal Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pneumococcal Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acon Labs Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Cepheid Inc., F-Hoffmann la Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc. by SD Biosensor, Novartis AG, Pfizer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Pneumococcal Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostic, and Point of Care Testing.
• Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Nucleic Acid Sequence Based Amplification, Polymerase Chain Reaction, and Western Blot Test.
• Based on Product Type, market is studied across Analyzers and Consumables.
• Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption of pneumococcal testing with improvement in early diagnosis and treatment
    • 5.1.1.2. Upsurge in the number of prevalence of pneumococcal disease
    • 5.1.1.3. Ongoing clinical trials for development of vaccines and drug molecules
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the development of pneumococcal testing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising popularity for POC tests
    • 5.1.3.2. Increasing R&D investments and advancements in testing technologies for in-vitro diagnostic (IVD)
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pneumococcal Testing Market, by Method

• 6.1. Introduction
• 6.2. Immunodiagnostics
• 6.3. Molecular Diagnostic
• 6.4. Point of Care Testing

7. Pneumococcal Testing Market, by Technology

• 7.1. Introduction
• 7.2. Enzyme Linked Immunosorbent Assay
• 7.3. Immunofluorescence
• 7.4. Immunohistochemistry
• 7.5. Nucleic Acid Sequence Based Amplification
• 7.6. Polymerase Chain Reaction
• 7.7. Western Blot Test

8. Pneumococcal Testing Market, by Product Type

• 8.1. Introduction
• 8.2. Analyzers
• 8.3. Consumables

9. Pneumococcal Testing Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Hospitals & Clinics

10. Americas Pneumococcal Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pneumococcal Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pneumococcal Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acon Labs Inc.
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. bioMerieux S.A.
• 6. Cepheid Inc.
• 7. F-Hoffmann la Roche Ltd.
• 8. Hologic, Inc.
• 9. Meridian Bioscience, Inc. by SD Biosensor
• 10. Novartis AG
• 11. Pfizer Inc.
• 12. Qiagen N.V.
• 13. Quest Diagnostics Incorporated
• 14. Thermo Fisher Scientific Inc.
• 15. Trinity Biotech PLC